NP / PA
Twelvestone Infusion Centers LLC
Twelvestone Infusion Centers LLC was paid $721K by Medicaid between Sep 2019 and Dec 2024, across 13 billing codes. Its largest line is Q5121, Injection, infliximab-axxq, biosimilar, (avsola), 10 mg — 44% of everything it billed.
33Billing provider infoTWELVESTONE INFUSION CENTERS LLC
MURFREESBORO, TN 37129
MURFREESBORO, TN 37129
33aNPI1447764857assigned 11/21/2017
33bProvider typeNurse Practitioner
28Total paid$721K
24GClaims6,214
24DCodes billed13
24AFirst – last monthSep 2019 – Dec 2024
Compared with peers
Next to other Nurse Practitioner providers in Tennessee
Rank by total paid#13 of 212
Median peer was paid$17K
This provider vs. median43×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 44 | $2K | |
| 2020 | 463 | $18K | |
| 2021 | 791 | $28K | |
| 2022 | 808 | $34K | |
| 2023 | 2,095 | $307K | |
| 2024incomplete | 2,013 | $332K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| Q5121 | Injection, infliximab-axxq, biosimilar, (avsola), 10 mg | 44% | 237 | 120 | $314K |
| 99601 | 28% | 2,959 | 1,791 | $200K | |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 15% | 49 | 45 | $110K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 8.2% | 1,310 | 868 | $59K |
| 99602 | Nursing care in home rn | 3.7% | 667 | 457 | $26K |
| 96415 | <1% | 336 | 214 | $4K | |
| S9379 | Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | <1% | 204 | 135 | $4K |
| 96401 | <1% | 43 | 27 | $907.56 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 147 | 102 | $801.60 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 78 | 40 | $620.14 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 42 | 27 | $230.94 |
| 36415 | Collection of venous blood by venipuncture | <1% | 74 | 42 | $69.22 |
1 more codes
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 68 | $36.97 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOLDEN, LEE (PRESIDENT)